Literature DB >> 17114428

Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.

Richard J Mellanby1, Chad H Koonce, Anthony Monti, Jenny M Phillips, Anne Cooke, Elizabeth K Bikoff.   

Abstract

The invariant (Ii) chain acts as an essential chaperone to promote MHC class II surface expression, Ag presentation, and selection of CD4(+) T cells. We have examined its role in the development of type 1 diabetes in NOD mice and show that Ii chain-deficient NOD mice fail to develop type 1 diabetes. Surprisingly, Ii chain functional loss fails to disrupt in vitro presentation of islet Ags, in the context of NOD I-A(g7) molecules. Moreover, pathogenic effector cells could be shown to be present in Ii chain-deficient NOD mice because they were able to transfer diabetes to NOD.scid recipients. The ability of these cells to transfer diabetes was markedly enhanced by depletion of CD25 cells coupled with in vivo anti-CD25 treatment of recipient mice. The numbers of CD4(+)CD25(+)Foxp3(+) T cells in thymus and periphery of Ii chain-deficient NOD mice were similar to those found in normal NOD mice, in contrast to conventional CD4(+) T cells whose numbers were reduced. This suggests that regulatory T cells are unaffected in their selection and survival by the absence of Ii chain and that an alteration in the balance of effector to regulatory T cells contributes to diabetes prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114428     DOI: 10.4049/jimmunol.177.11.7588

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.

Authors:  Woelsung Yi; Nilufer P Seth; Tom Martillotti; Kai W Wucherpfennig; Derek B Sant'Angelo; Lisa K Denzin
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

Review 2.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

3.  Diabetes-related impairment in bone strength is established early in the life course.

Authors:  Krista Casazza; Lynae J Hanks; Gregory A Clines; Hubert M Tse; Alan W Eberhardt
Journal:  World J Diabetes       Date:  2013-08-15

Review 4.  On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.

Authors:  Robert Busch; Alessandra De Riva; Andreas V Hadjinicolaou; Wei Jiang; Tieying Hou; Elizabeth D Mellins
Journal:  Expert Rev Mol Med       Date:  2012-07-06       Impact factor: 5.600

5.  The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice.

Authors:  Marc A J Morgan; Pari S S Muller; Arne Mould; Stephen A Newland; Jennifer Nichols; Elizabeth J Robertson; Anne Cooke; Elizabeth K Bikoff
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 6.  Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes.

Authors:  Zemin Zhou; Peter E Jensen
Journal:  Front Immunol       Date:  2013-08-29       Impact factor: 7.561

7.  Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.

Authors:  Yang D Dai; Idania G Marrero; Philippe Gros; Habib Zaghouani; Linda S Wicker; Eli E Sercarz
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

Review 8.  CD74 in Kidney Disease.

Authors:  Lara Valiño-Rivas; Ciro Baeza-Bermejillo; Laura Gonzalez-Lafuente; Ana Belen Sanz; Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Front Immunol       Date:  2015-09-23       Impact factor: 7.561

Review 9.  Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.

Authors:  Jean-Simon Fortin; Maryse Cloutier; Jacques Thibodeau
Journal:  Front Immunol       Date:  2013-12-13       Impact factor: 7.561

Review 10.  MHC Class II Protein Turnover In vivo and Its Relevance for Autoimmunity in Non-Obese Diabetic Mice.

Authors:  Alessandra De Riva; Robert Busch
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.